The abstract is read at the publisher; the summary is JClub's.
In the 5×FAD mouse model of amyloidosis, maladaptive type I interferon signaling disrupts bone marrow myelopoiesis and limits monocyte homing to the brain.
- Why it matters: Bone marrow-derived macrophages can reduce AD inflammation when recruited, but the systemic signals that restrict their spontaneous brain entry were unclear.
- What they did: The study assessed monocyte development in 5×FAD mice and in AD patients, then blocked IFN-I signaling with neutralizing antibodies or reconstituted 5×FAD mice with IFN-I receptor–deficient bone marrow.
- The result: IFN-I pathway inhibition restored myelopoiesis and normalized monocyte phenotypes, increased monocyte-derived macrophage homing to the brain, and ameliorated disease pathology.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.